2023 Science Innovation Seed Funding Awards
Hudson Institute’s Research Committee has announced this year’s recipients of the Science Innovation Seed Funding Awards.
The awards provide seed funding to support innovative blue-sky ideas, interdisciplinary research, and collaborations between researchers. This seed funding allows researchers to gather the baseline data for out-of-the-box ideas and provides a clear pathway to sustainable funding.
“Seed funding is crucial for starting innovative research projects and collecting critical data needed to secure funding. Importantly, this funding also connects researchers across centres – building multi-disciplinary teams that bring unique perspectives and resources to challenge the status quo.” Professor Ron Firestein, co-chair, Hudson Institute Research Committee.
Hudson Institute researchers will receive four awards of $30,000 each to support collaborative projects at the postdoctoral research level, and four awards of $50,000 each to support collaborative projects by senior researchers. In addition, two new special awards in the field of paediatric cancer were announced – one of up to $30,000 to support a researcher at the postdoctoral research level and another of up to $50,000 at the Group Head level.
Congratulations to all the 2023 recipients of the Science Innovation Seed Funding Awards.
Science Innovation Seed Funding award recipients
Postdoctoral Researcher award recipients
Project: Understanding how bacteria remodel the intestine to cause disease
Project: Understanding Wnt/β-catenin signalling regulation using human tumour and iPS cell-derived normal intestinal organoids
Senior researcher award recipients
Project: Novel therapeutics for maternal childbirth injury
Project: Delineating the immunopeptidome of testis germ cell tumours (TGCTs)
Paediatric cancer researcher awards
Paediatric cancer postdoctoral researcher award recipients
Dr Paul Daniel (CCR) and Terry Lim (CCR)
Project entitled: A novel phospho-proteomic signature to inform the use of clinically relevant inhibitors in paediatric high-grade glioma
Paediatric cancer senior researcher award recipients
Hudson Institute communications
t: + 61 3 8572 2761